Los Angeles Capital Management
MRVI icon

Los Angeles Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Los Angeles Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,593
Closed -$187K – 1246
2024
Q1 		$187K Buy
+21,593
New +$146K ﹤0.01% 1110
2023
Q4 		– Sell
-10,187
Closed -$102K – 1200
2023
Q3 		$102K Sell
10,187
-2,032
-17% -$22.3K ﹤0.01% 1091
2023
Q2 		$152K Hold
12,219
– – ﹤0.01% 1128
2023
Q1 		$171K Hold
12,219
– – ﹤0.01% 1131
2022
Q4 		$175K Buy
+12,219
New +$192K ﹤0.01% 1148
2022
Q3 		– Sell
-81,092
Closed -$2.3M – 1327
2022
Q2 		$2.3M Sell
81,092
-33,103
-29% -$1.05M 0.01% 504
2022
Q1 		$4.03M Buy
114,195
+66,134
+138% +$2.22M 0.02% 395
2021
Q4 		$2.01M Buy
48,061
+11,974
+33% +$485K 0.01% 512
2021
Q3 		$1.77M Sell
36,087
-417,506
-92% -$20.4M 0.01% 558
2021
Q2 		$18.9M Buy
+453,593
New +$17.6M 0.08% 208

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Los Angeles Capital Management's MRVI Position: Q2 2024 in Review

Los Angeles Capital Management sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 21,593 shares — an estimated $187K sold.

Los Angeles Capital Management first reported a position in MRVI in Q2 2021 and held it in 10 quarters. The position peaked at $18.9M in Q2 2021. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • Los Angeles Capital Management reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Los Angeles Capital Management sold 21,593 Maravai LifeSciences shares in Q2 2024, an estimated $187K.
  • Los Angeles Capital Management first reported a position in Maravai LifeSciences in Q2 2021 and held it in 10 quarters.
  • Los Angeles Capital Management's Maravai LifeSciences position peaked at $18.9M in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Los Angeles Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.